Postnatal oral hydrocortisone in treatment of bronchopulmonary dysplasia: an observational study

Mutlu, Banu; Sandal, Gonca; Kanmaz, Gozde; Eraslan, Zeynep; Erdeve, ÖMER; Oguz, Serife; Dilmen, Ugur

doi:10.5578/tt.4066

Postnatal oral hydrocortisone in treatment of bronchopulmonary dysplasia: an observational study

Mutlu B., Sandal G., Kanmaz G., Eraslan Z., Erdeve Ö., Oguz S. S., ...Daha Fazla

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, cilt.61, sa.3, ss.245-249, 2013 (ESCI, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 61 Sayı: 3
Basım Tarihi: 2013
Doi Numarası: 10.5578/tt.4066
Dergi Adı: TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.245-249
Anahtar Kelimeler: Bronchopulmonary dysplasia, hydrocortisone, preterm infant, CHRONIC LUNG-DISEASE, NEONATAL DEXAMETHASONE TREATMENT, SCHOOL-AGE, NEURODEVELOPMENTAL OUTCOMES, INFANTS
Ankara Üniversitesi Adresli: Evet

Özet

Introduction: The aim of our study was to determine whether hydrocortisone even at low dose could be an effective and safe alternative treatment for bronchopulmonary dysplasia.